Continuing Appropriations Act, 2023

Pub. L. 117-180

Also known as: Biosimilar User Fee Amendments of 2022, FDA User Fee Reauthorization Act of 2022, Generic Drug User Fee Amendments of 2022, Medical Device User Fee Amendments of 2022, Hermit's Peak/Calf Canyon Fire Assistance Act, Prescription Drug User Fee Amendments of 2022, Ukraine Supplemental Appropriations Act, 2023, United States Parole Commission Extension Act of 2022, Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023

45 sections of the Code credited to this law, found between Public Law 117-177 and Public Law 117-185.

• 18 U.S.C. § 3014 — Additional special assessment
• 21 U.S.C. § 355 — New drugs
• 21 U.S.C. § 360d — Performance standards
• 21 U.S.C. § 360j — General provisions respecting control of devices intended for human use
• 21 U.S.C. § 360m — Accredited persons
• 21 U.S.C. § 360ee — Grants and contracts for development of drugs for rare diseases and conditions
• 21 U.S.C. § 360bbb–5 — Critical Path Public-Private Partnerships
• 21 U.S.C. § 374 — Inspection
• 21 U.S.C. § 379g — Definitions
• 21 U.S.C. § 379h — Authority to assess and use drug fees
• 21 U.S.C. § 379h–2 — Reauthorization; reporting requirements
• 21 U.S.C. § 379i — Definitions
• 21 U.S.C. § 379j — Authority to assess and use device fees
• 21 U.S.C. § 379j–1 — Reauthorization; reporting requirements
• 21 U.S.C. § 379j–42 — Authority to assess and use human generic drug fees
• 21 U.S.C. § 379j–43 — Reauthorization; reporting requirements
• 21 U.S.C. § 379j–51 — Definitions
• 21 U.S.C. § 379j–52 — Authority to assess and use biosimilar biological product fees
• 21 U.S.C. § 379j–53 — Reauthorization; reporting requirements
• 38 U.S.C. § 111A — Transportation of individuals to and from Department facilities
• 38 U.S.C. § 315 — Regional offices
• 38 U.S.C. § 322 — Office of National Veterans Sports Programs and Special Events
• 38 U.S.C. § 503 — Administrative error; equitable relief
• 38 U.S.C. § 521A — Adaptive sports programs for disabled veterans and members of the Armed Forces
• 38 U.S.C. § 544 — Advisory Committee on Minority Veterans
• 38 U.S.C. § 1710 — Eligibility for hospital, nursing home, and domiciliary care
• 38 U.S.C. § 1710A — Required nursing home care
• 38 U.S.C. § 2021 — Homeless veterans reintegration programs
• 38 U.S.C. § 2021A — Homeless women veterans and homeless veterans with children reintegration grant program
• 38 U.S.C. § 2031 — General treatment
• 38 U.S.C. § 2033 — Additional services at certain locations
• 38 U.S.C. § 2044 — Financial assistance for supportive services for very low-income veteran families in permanent housing
• 38 U.S.C. § 2061 — Grant program for homeless veterans with special needs
• 38 U.S.C. § 2066 — Advisory Committee on Homeless Veterans
• 38 U.S.C. § 2102A — Assistance for individuals residing temporarily in housing owned by a family member
• 38 U.S.C. § 2108 — Specially adapted housing assistive technology grant program
• 38 U.S.C. § 3692 — Advisory committee
• 38 U.S.C. § 8111 — Sharing of Department of Veterans Affairs and Department of Defense health care resources
• 38 U.S.C. § 8118 — Authority for transfer of real property; Department of Veterans Affairs Capital Asset Fund
• 42 U.S.C. § 233 — Civil actions or proceedings against commissioned officers or employees
• 42 U.S.C. § 284m — Program for pediatric studies of drugs
• 42 U.S.C. § 1395ww — Payments to hospitals for inpatient hospital services
• 42 U.S.C. § 1395iii — Medicare Improvement Fund
• 42 U.S.C. § 1396d — Definitions
• 47 U.S.C. § 309 — Application for license